Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors

The Spike receptor binding domain (S-RBD) from SARS-CoV-2, a crucial protein for the entrance of the virus into target cells is known to cause infection by binding to a cell surface protein. Hence, reckoning therapeutics for the S-RBD of SARS-CoV-2 may address a significant way to target viral entry...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rahul, Bhardwaj, Vijay Kumar, Sharma, Jatin, Kumar, Dinesh, Purohit, Rituraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264305/
https://www.ncbi.nlm.nih.gov/pubmed/34273770
http://dx.doi.org/10.1016/j.compbiomed.2021.104631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264305/
https://www.ncbi.nlm.nih.gov/pubmed/34273770
http://dx.doi.org/10.1016/j.compbiomed.2021.104631

Ejemplares similares